Tenth, 25^th, 50^th, 75^th, and 90^th percentiles of HCV RNA level in relation to <i>IL28B</i>.

<p>Tenth, 25^th, 50^th, 75^th, and 90^th percentiles of HCV RNA level in relation to <i>IL28B</i>.</p

Study enrollment and disposition of patients.

<p>Study enrollment and disposition of patients.</p

Baseline characteristics of patients with a valid liver stiffness measurement.

<p>Values are expressed as n^a, median (IQR)^b or percentage^e</p>c<p>n = 318, n = 34, and n = 91 for genotype 1, 2, and 3 respectively</p>d<p>n = 152, n = 6, and n = 51 for genotype 1, 2, and 3 respectively</p

Frequency distribution of <i>IL28B</i> variants in relation to HCV genotypes 1-3 among treatment-naïve patients.

<p>Chi-squared (<i>χ</i>²)-test was used to compare differences in distribution.</p

Tenth, 25^th, 50^th, 75^th, and 90^th percentiles of APRI score in relation to <i>IL28B</i> variants for genotypes 1, 2 and 3.

<p>Tenth, 25^th, 50^th, 75^th, and 90^th percentiles of APRI score in relation to <i>IL28B</i> variants for genotypes 1, 2 and 3.</p

Baseline characteristics according to HCV genotype and IL28 B genetic variations (<i>rs12979860</i>).

<p>Values are expressed as median (IQR)^a or n^b</p>c<p>n = 173 genotype 1, n = 58 genotype 3</p>d<p>n = 373 genotype 1, n = 109 genotype 3</p

Impact of <i>IL28B</i> (<i>rs12979860</i>) on normalized ALT and AST to platelet ratio index (APRI) among HCV genotype 2 and 3 infected patients.

<p>Box plots displaying the 10^th, 25^th, 50^th, 75^th, and 90^th percentiles and p-values obtained using Kruskal-Wallis test.</p

Baseline Characteristics with Patients Grouped According to HCV genotype and <i>IL28B</i> Genetic Variations (<i>rs12979860</i>).

<p>Data presented as median (25^th–75th percentile)^a or n^b.</p

Association between <i>IL28B</i> (<i>rs12979860</i>) and portal inflammation grade (Ishak protocol) and steatosis grade among HCV genotype 2 and 3 infected patients.

<p>Histogram displaying the proportion of patients, and p-value obtained using Chi-squared test.</p

Impact of <i>IL28B</i> (<i>rs12979860</i>) on baseline viral load and decline in mean HCV RNA day 0–3 among HCV genotype 2 and 3 infected patients.

<p>Box plots displaying the 10^th, 25^th, 50^th, 75^th, and 90^th percentiles, and p-values obtained using Kruskal-Wallis test.</p